These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 6211804)

  • 21. Cellular immunogenetics of HLA: quantitative crossmatches for LD and CD determinants.
    Bach FH
    Transplant Proc; 1978 Mar; 10(1):63-6. PubMed ID: 76353
    [No Abstract]   [Full Text] [Related]  

  • 22. Significance of HLA and non-HLA antigens in bone marrow transplantation.
    Opelz G; Gale RP; Feig SA; Walker J; Terasaki PI; Saxon A
    Transplant Proc; 1978 Mar; 10(1):43-6. PubMed ID: 24908
    [No Abstract]   [Full Text] [Related]  

  • 23. Cellular interactions in marrow-grafted patients. II. Normal monocyte antigen-presenting and defective T-cell-proliferative functions early after grafting and during chronic graft-versus-host disease.
    Tsoi MS; Dobbs S; Brkic S; Ramberg R; Thomas ED; Storb R
    Transplantation; 1984 Jun; 37(6):556-61. PubMed ID: 6233768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Current concepts of the growth mechanisms of the immune response].
    Voĭtenok NN
    Ter Arkh; 1980; 52(9):132-40. PubMed ID: 6449091
    [No Abstract]   [Full Text] [Related]  

  • 25. Bone marrow transplanation for severe combined immunodeficiency with the HL-A-incompatible but MLC-identical mother as a donor.
    Neithammer D; Goldmann SF; Haas RJ; Dietrich M; Flad HD; Fliedner TM; Kleihauer E
    Transplant Proc; 1976 Dec; 8(4):623-8. PubMed ID: 11594
    [No Abstract]   [Full Text] [Related]  

  • 26. Graft-versus-host disease.
    Gatti RA; Kersey JH; Yunis EJ; Good RA
    Prog Clin Pathol; 1973; 5():1-18. PubMed ID: 4150104
    [No Abstract]   [Full Text] [Related]  

  • 27. [Available methods to modify primary graft rejection (author's transl)].
    Prange CH; Kliems G
    Wien Klin Wochenschr; 1977 Jul; 89(14):465-74. PubMed ID: 302531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Graft-vs-leukemia following bone marrow transplantation: a model of immunotherapy in man.
    Butturini A; Bortin MM; Seeger RC; Gale RP
    Prog Clin Biol Res; 1987; 244():371-90. PubMed ID: 3310000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T and B cell deficiencies in patients with chronic graft-versus-host disease after HLA-identical marrow transplantation.
    Lum LG; Seigneuret MC; Storb R; Witherspoon RP; Thomas ED
    Transplant Proc; 1981 Mar; 13(1 Pt 2):1231-2. PubMed ID: 7022930
    [No Abstract]   [Full Text] [Related]  

  • 30. Successful bone marrow transplantation in sensitized recipients.
    Levey RH; Parkman R; Rappeport J; Nathan DG; Rosen F
    Transplant Proc; 1979 Mar; 11(1):199-204. PubMed ID: 377631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of anti-non-MHC-directed T cell reactivity following in vivo priming after HLA-identical marrow transplantation and following in vitro priming in limiting dilution cultures.
    Irlé C; Chapuis B; Jeannet M; Kaestli M; Montandon N; Speck B
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2674-7. PubMed ID: 3547946
    [No Abstract]   [Full Text] [Related]  

  • 32. Bone marrow transplantation across the major histocompatibility barrier in specific-pathogen-free mice: effects of intact versus T cell-depleted bone marrow on the expression of anti-host reaction in the recipient spleens.
    Muto M; Sado T; Aizawa S; Kamisaku H; Kubo E
    J Immunol; 1981 Dec; 127(6):2421-5. PubMed ID: 6457876
    [No Abstract]   [Full Text] [Related]  

  • 33. Bone marrow transplantation.
    Santos GW
    Adv Intern Med; 1979; 24():157-82. PubMed ID: 34319
    [No Abstract]   [Full Text] [Related]  

  • 34. Transplantation of HLA-mismatched marrow depleted of T-cells by lectin agglutination and E-rosette depletion.
    O'Reilly RJ; Collins N; Dinsmore R; Kernan N; Siena S; Brochstein J; Kirkpatrick D; Flomenberg N; Shank B; Dupont B
    Tokai J Exp Clin Med; 1985 Jun; 10(2-3):99-107. PubMed ID: 3914748
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunocompetence in regional graft-versus-host reaction of blood cells from skin allografted or ALS treated rats.
    Hasková V; Gansová E; Hajná I
    Folia Biol (Praha); 1973; 19(4):261-6. PubMed ID: 4148073
    [No Abstract]   [Full Text] [Related]  

  • 36. Specific suppressor cells and immune response to host antigens in long-term human allogeneic marrow recipients: implications for the mechanisms of graft-host tolerance and chronic graft-versus-host disease.
    Tsoi MS; Storb R; Dobbs S; Santos E; Thomas ED
    Transplant Proc; 1981 Mar; 13(1 Pt 1):237-40. PubMed ID: 6455791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of proliferative capacity and T cell immune development potential by bone marrow from mice undergoing a graft-vs-host reaction.
    Iwasaki T; Fujiwara H; Iwasaki T; Shearer GM
    J Immunol; 1986 Nov; 137(10):3100-8. PubMed ID: 2945856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct and antibody-dependent cell-mediated cytotoxicity against HLA identical sibling lymphocytes. Correlation with marrow graft rejections.
    Warren RP; Storb R; Weiden PL; Mickelson EM; Thomas ED
    Transplantation; 1976 Dec; 22(6):631-5. PubMed ID: 137561
    [No Abstract]   [Full Text] [Related]  

  • 39. Dissociation of lymphocyte activation and graft-versus-host competence of blood cells after skin grafting in rats treated with antithymocyte and normal pig serum.
    Hasková V; Korcáková L; Bednarík T
    Transplantation; 1973 Oct; 16(4):325-30. PubMed ID: 4147638
    [No Abstract]   [Full Text] [Related]  

  • 40. Antilymphocyte serum: mechanism of action.
    Lance EM
    Transplant Proc; 1972 Dec; 4(4):473-5. PubMed ID: 4566790
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.